Skip to main content
FinSpry Logo
FinSpry
AKBA logo
AKBA
(NASDAQ)
Akebia Therapeutics, Inc.
$0.95-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Akebia Therapeutics (AKBA) Stock Price & Financial Analysis

Akebia Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.95 - $1.03
52-Week High$3.20
52-Week Low$0.81
Open$0.96
Volume3.05M
Average Volume (3M)7.51M
Market Cap254.74M
Shares Outstanding267.05M
Price to Sales (P/S)1.10
Price to Book (P/B)9.31
EV/EBITDA83.80
Revenue (TTM)232.40M
Net Income (TTM)-20.51M
Free Cash Flow (TTM)59.95M
EPS (TTM)$-0.08
Profit Margin-8.83%
Operating Margin2.28%
Return on Equity (ROE)-74.93%
Debt to Equity0.46
50-Day MA$1.12
200-Day MA$1.29
52-Week Change-68.20%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Akebia Therapeutics

What is the current stock price for AKBA?

As of the latest trading session, AKBA stock trades at $1.03. The 52-week range is $0.81–$3.20, with a day range of $0.95–$1.03.

What is the P/E ratio for AKBA?

The P/E ratio (Price-to-Earnings) for AKBA is shown in the Key Statistics section. This valuation metric helps compare Akebia Therapeutics, Inc. to industry peers.

Does AKBA pay dividends?

Akebia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AKBA?

Based on 2 analysts, the consensus for AKBA is Buy.

What is the market cap of AKBA?

Akebia Therapeutics's market capitalization is $275.1M, classifying it as a micro-cap company. Akebia Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.